Swiss Health Insurance Premiums Surge as Baumol Cost Disease Drives Medical Expenses
Swiss health insurance premiums have more than doubled since 1999 while wages grew modestly, a pattern economists link to the Baumol cost disease.
In Switzerland, health-insurance premiums have more than doubled since 1999, outpacing wage growth that has risen only modestly in the same period. This divergence mirrors a broader trend where goods become cheaper while services, especially medical care, become more expensive. The phenomenon matches William Baumol's cost disease theory, which argues that rising wages in highly productive industries lift labor costs in sectors that cannot increase productivity, such as health care.
Swiss federal finance researchers have identified this effect as a primary factor behind rising health-care expenditures, a finding echoed by an OECD-wide study. While robot-assisted surgeries can reduce patient stay lengths, the high cost of equipment and a surge in procedures keep total costs high. The analysis suggests that the rising premiums reflect greater consumption of advanced medical services rather than simple price inflation.
Why it matters
Understanding the cost disease explains why health premiums keep rising despite overall price stability in other areas.
In this story
